Physician profile
Muhammad W Raqeem
NPI 1598050494
$1,456.93
in general payments reported to CMS, 2019-2025
17 companies · $80.17 in 2025
The $80.17 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $62.28 · 2021: $381 · 2022: $217 · 2025: $80.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.63 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.63 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $427.32 | 2019-2022 | |
| Allergan, INC. | $282.31 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $162.58 | 2021 | |
| Advanced Respiratory, INC | $78.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $77.04 | 2019-2021 | |
| Abbvie INC. | $69.07 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.49 | 2019-2021 | |
| Melinta Therapeutics, LLC | $43.47 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $42.57 | 2019-2021 | |
| Lundbeck LLC | $38.54 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $36.12 | 2019 | |
| Pfizer INC. | $34.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.00 | 2019 | |
| Insmed, INC. | $21.76 | 2019 | |
| Gilead Sciences, INC. | $18.79 | 2025 | Veklury |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyera Pharmaceuticals, LLC | $16.73 | 2019 | |
| Vapotherm INC | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Raqeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.